Saturday, July 11, 2026

pharma · Ischemic Stroke · Spinal Cord Injury

Neuroscience Trials Australia

Neuroscience Trials Australia trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Parkville, AU HQ
14 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Parkville, AU
Employees
14
Programs
5
Drugs
9
Patents
0
Intelligence · Clinical Trials

Neuroscience Trials Australia clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Neuroscience Trials Australia programs — each row shows trial ID, program name, phase, status, and indication.

Neuroscience Trials Australia trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for Neuroscience Trials Australia.

  1. Tranexamic Acid — Phase 2

    Clinical update
  2. Tissue Plasminogen Activator (Alteplase) — Phase 3

    Clinical update
  3. Tenecteplase — Phase 2

    Clinical update
  4. Direct endovascular clot retrieval — Phase 3

    Clinical update
  5. Bone marrow derived stem cells — Phase 2

    Clinical update

Trial registry

5 studies